Zusammenfassung
Das Mesotheliom ist der häufigste primäre Pleuratumor. Gleichwohl gehören die malignen Mesotheliome zu den selteneren Tumorerkrankungen (Weiss u. Muggia 1979; Aisner u. Wiernik 1978). Als bedeutendster ätiologischer Faktor für die Entwicklung maligner Mesotheliome gilt die Asbestexposition (Taryle et al. 1962; Cochrane u. Webster 1978; Legha u. Muggia 1977; Whitewell u. Raw-cliffe 1971). Es handelt sich um aggressiv wachsende Tumoren. Die mediane Überlebenszeit unbehandelter Patienten beträgt ca. 12 Monate (Legha u. Muggia 1977 a; Aisner u. Wiernik 1981; Alberts et al. 1988).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aisner J, Wiernik PH (1978) Malignant mesothelioma. Current status and future prospects. Chest 74: 438–444
Aisner J, Wiernik PH (1981) Chemotherapy in the treatment of malignant mesothelioma. Semin Oncol 8: 335–343
Alberts AS, Falkson G, Goldhals L, Vorobiof DA, van der Merwe CA (1988) Malignant pleural mesothelioma: a disease unaffected by current therapeutic manoeuvres. JCO 6/ 3: 527–535
Baldini EH, Recht A, Strauss GM et al. (1997) Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 63: 334–338
Ball DL, Cruickshank DG (1990) The treatment of malignant mesothelioma of the pleura: review of a 5 year experience, with special reference to radiotherapy. Am J Clin Oncol: 13: 4–9
Belani CP, Herdon J, Vogelzwang NJ, Green MR (1994) Edatrexate for malignant mesothelioma: A phase II-study of the Cancer and Leukemia Group B. Proc ASCO 13 /339: 1087
Bischoff HG, Branscheid D, Probst G (1991) Chirurgische Therapie beim malignen Pleuraerguß. Z Herz Thorax Gefäßchir 5: 173–177
Bissett D, Macbeth FR, Cram I (1991) The role of palliative radiotherapy in malignant mesothelioma. Clin Oncol (R Coll Radiol) 3: 315–317
Boutin C, Cagnino P, Viallat JR (1980) Thoracoscopy in the early diagnosis of malignant pleural effusions. Endoscopy 12: 155
Boutin C, Rey F, Viallat JR (1995) Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 108: 754–758
Branscheid D, Bischoff H, Vogt-Moykopf I (1988) Chirurgie der malignen Pleuraergüsse einschließlich des malignen Pleura-Mesothelioms. In: Hossfeld DK, Gatzenmeier U (Hrsg) Maligne Ergüsse. Karger, Basel ( 33, S 81–97 )
Butchart E, Ashcroft T, Barnsley W, Holden M (1976) Pleuropneomonectomy in the management of diffuse malignant mesothelioma of the pleura. Thorax 31: 15–24
Cochrane JC, Webster J (1978) Mesothelioma in relation to asbestos fiber exposure. A review of 70 serial cases. South Afr Med J 54: 279–281
Colbert N, Vannetel IM, Izrael V et al. (1985) A prospective study of etorubicin in malignant mesothelioma. Cancer 56: 2170–2174
Dabouis G, Lemevel B, Corroler J (1981) Treatment of diffuse pleural malignant mesothelioma by disdichlorodiamineplatinum (CDDP) in nine patients. Cancer Chemother Pharmacol 5: 209–210
Duhin JT (1969) Solitary rhabdomyosarcoma of the pleura. Report of a case with a note on the nomenclature of pleura tumors. J Thorax Cardiovasc Surg 37: 236–241
Eisenhauer EA, Evans WK, Raghaven D et al. (1986) Phase II stuay of mitoxantrone in patients with mesothelioma: A National Cancer Institute of Canada Clinical Trials Group study. Cancer Treat Rep 70: 1029–1030
Eimes PC, Simpson MJC (1976) The clinical aspects of mesothelioma. Q J Med 45: 427–449
Fentiman IS, Millis R, Sexton S, Hayward JL (1981) Pleural effusion in breast cancer. Cancer 47: 2087–2092
Frank W, Großer H, Mai J, Loddenkemper R (1989) Pleurodese mit Tetracyclin-Hydro-chlorid. Pneumologie 43: 80–84
Gupta RK, Paolini FA (1967) Liposarcoma of the pleura, report of a case with a review of the literature and views on histogenesis. Am Rev Respir Dis 95: 298–304
Hausheer FH, Yarbo JW (1985) Diagnosis and treatment of malignant pleural effusion. Semin Oncol 12: 54–75
Henß H, Fiebie HH, Schildge J, Arnold H, Hass J (1988) Phase-II study with the combination of cisplatin and doxorubicin in advanced malignant mesothelioma of the pleura. Onkologie II: 118–120
Hilaris BS, Dattatreyudu N, Kwong E, Kutcher GK, Martini N (1984) Pleurectomy and intraoperative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 10: 325–331
Kirmani S, Cleory SM, Mowry J, Hawell SB (1988) Intracavitary cisplatin for malignant mesothelioma; an update. Proc ASCO 7: 273
Kreuser ED, Seyfried E, Hartmann R, Schreml W, Rasche U (1984) Behandlung maligner Pleuraergüsse durch Fibrinklebung. Tumor Diagn Ther 5: 55–58
Kutcher GJ, Kestler C, Greenblatt D, Brenner H, Hilaris BS, Nori D (1987) Technique for external beam treatment for mesothelioma. Int J Radiat Oncol Biol Phys 13: 1747–1752
Law MR, Gregor A, Hodson ME, Bloom HJG, Turner-Warwick M (1984) Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax 39: 255–259
Legha S, Muggia FM (1977 a) Therapeutic approaches to malignant mesothelioma. Cancer Treat Rev 4: 13–25
Legha S, Muggia FM (1977 b) Pleural mesothelioma: clinical features and therapeutic implications. Ann Intern Med 87: 613–621
Lerner HJ, Schoenfeld DA, Martin A, Falkson G, Borden E (1983) Malignant mesothelioma, the Eastern Cooperative Oncology Group (ECOG) experience. Cancer 52: 1981–1985
Linden CJ, Mercke C, Albrechtsson U, Johansson L, Ewers SB (1996) Effect of hemithorax irradiation alone or combined with doxorubicin and cyclophosphamide in 47 pleural mesotheliomas: a nonrandomized phase II study. Eur Respir J 9: 2565–2572
Magri MD, De Giovanni D, Serra C et al. (1988) Epirubicin treatment of mesothelioma: A phase-II study. Proc ASCO 7: 207
Marley MRS (1979) Malignant pleural effusions and their treatment by intercostal tale pleurodesis. Br J Dis Chest 73: 173–177
Martini N, Bains MS, Beattie EJ (1975) Indications for pleurectomy in malignant effusion. Cancer 35: 734
Meerbeck J van, Debruyne C, Postmus PE, Groen HJM, Manegold C et al. (1996) Sequential phase II studies with paclitaxel and gemcitabine in malignant pleural mesothelioma. Eur Res J 9 (Suppl 23) 400 s: 2513
Mintzer DM, Nelsen D, Frinner D, Meelan R, Gralla R (1985) Phase II trial of high-dose cisplatin in patients with malignant mesothelioma. Cancer Treat Rep 69: 711–712
Moore M, Andersen J, Burris H et al. (1995) A randomized trial of gemcitabine vs. 5-FU as first-line therapy in advanced pancreatic cancer. Proc ASCO 14: 1099, 473
Müsch E, Paar WD, Hoffmann B et al. (1989) Intrapleurale Instillation von Mitoxantron zur Palliativtherapie maligner Pleuraergüsse. Tumor Diagn Ther 10: 64–71
Ong ST, Vogenzwang NJ (1996) Current therapeutic appraoches to unresectable (primary and recurrent) disease. In: Aisner J, Arriagada R, Green MR, Martini N, Perry MC (eds) Comprehensive textbook of thoracic oncology, zz, Baltimore, pp 799–812
Ostrowski MJ (1989) Intracavitary therapy with Bleomycin for the treatment of malignant pleural effusions. J Sure Oncol (Suppl I ): 7–13
Pfeifle CE, Howell SB, Markman M (1985) Intracavitary cisplatin chemotherapy for mesothelioma. Cancer Treat Rep 69: 205–207
Roberts GH (1976) Distant with drawl metastases in pleural mesothelioma. Br J Dis Chest 70: 246–250
Salver WR, Eggleston JC, Erozan YS (1975) Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. Chest 67: 536
Samson MK, Wasser LP, Borden EC et al. (1987) Randomized comparison of cyclophosphamide, imidazole carboxamied, and adriamycin vs. cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: A Sarcoma Inter-group Study. JCO 5 /1: 86–91
Sauer H, Kremer G, Wilmanns W (1987) Zur Toxizität einer CYVADIC-Modifikation bei Patienten mit Weichteilsarkomen oder malignen Mesotheliomen. Onkologie 10: 294–300
Sauter ER, Langer C, Coia LR, Goldberg M, Keller SM (1995) Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation. J Surg Oncol 60: 100–105
Selikoff IY, Churg J, Hammond FC (1965) Relations between exposure to asbestos and mesothelioma. N Engl J Med 272: 560–565
Shuman LS, Libshutz HI (1984) Pictorial essay. Solid pleural manifestations of lymphoma. AJR 142: 269–273
Solheim OP, Saeter G, Finnanger AM (1992) High dose methotrexate in the treatment of malignant mesothelioma of the pleura. A phase II study. Br J Cancer 65: 956–960
Sörensen PG, Bach F, Bork E, Hansen HW (1985) Randomized trial of doxorubicin vs. cyclophosphamide in diffuse malignant pleural mesothelioma. Cancer Treat Rep 69: 1431–1432
Soubra M, Dunscombe PB, Hodson DI, Wong G (1990) Physical aspects or external beam radiotherapy for the treatment of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 18: 1521–1527
Sugarbaker DJ, Garcia JP, Richards WG et al. (1996) Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg 224: 288–94
Taryle DA, Lakshininarayan S, Sahn SA (1962) Pleural mesotheliomas — an analysis of 18 cases and review of the literature. Medicine 55: 153–162
Vogelzwang NJ, Goutson M, Graziano S, Aisner J, Cooper MR, Modeas C, Green MR (1989) Carboplatin in malignant mesothelioma. A phase II-study of the CALGB. Proc ASCO 8: 321
Vogelzwang NJ, Herndorn J, Clamon GH, Maurer AM, Cooper MR, Green MR (1994) Paclitaxel (Taxol) for malignant mesothelioma: a phase II-study of the Cancer and Leukemia Group B (CALGB 9234) (Abstr). Proc ASCO 13: 405
Wagner JC (1965) Epidemiology of diffuse mesothelial tumors: Evidence of an association from studies in South Africa and United Kingdom. Ann NY Acad Sci 132: 575–578
Weiss RB, Muggia FM (1979) Working conference on mesothelioma treatment trials. Cancer Res 33: 799 - 800
Whitewell F, Rawcliffe RM (1971) Diffuse malignant pleura mesothelioma and asbestos exposure. Thorax 26: 6–22
Winkelmann M, Pfitzer P (1981) Blind pleural biopsy in combination with cytology of pleural effusions. Acta Cytol (Baltimore) 25: 373
Yang HY, Weaver LI, Foti PR (1983) Primary malignant fibrous histiocytoma of the pleura. Acta Cytol (Baltimore) 27: 683–687
Zafoznik AJ, Oswald SG, Langin M (1983) Intrapleural tetracycline in malignant pleural effusions. Cancer 51: 752–755
Zidar B, Bugh R, Schiffer L, Raju R, Vaidya K, Home D, Baker L (1983) Treatment of 6 cases of mesothelioma with doxorubicin and cisplatinum. Cancer 52: 1788–1791
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Manegold, C., Schraube, P., Bischoff, H. (1998). Nichtoperative Behandlung primärer und sekundärer Pleuratumoren. In: Drings, P., Vogt-Moykopf, I. (eds) Thoraxtumoren. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72041-3_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-72041-3_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72042-0
Online ISBN: 978-3-642-72041-3
eBook Packages: Springer Book Archive